Mixed Glioma

9 registered clinical trials studyying Mixed Glioma.

Status	Trial	Sponsor	Phase
Withdrawn	Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas NCT02976441	Washington University School of Medicine	EARLY_Phase 1
Completed	Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma NCT02101905	National Cancer Institute (NCI)	Phase 1
Terminated	Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance De NCT02372409	Washington University School of Medicine	Phase 2
Completed	Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas NCT02238496	Andrew B Lassman, MD	Phase 1
Completed	Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma NCT01250470	Roswell Park Cancer Institute	Phase 1
Completed	Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions NCT01082926	City of Hope Medical Center	Phase 1
Terminated	Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma NCT01095094	Case Comprehensive Cancer Center	Phase 2
Completed	Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme NCT00390299	Mayo Clinic	Phase 1
Completed	Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previo NCT00303849	OHSU Knight Cancer Institute	Phase 1 / Phase 2